Scans	N = 78
Patient Demographics: n (%) Prostatectomy Radiation Hormonal Therapy Prostatectomy & Radiation Prostatectomy & Hormonal Therapy Radiation & Hormonal Therapy Prostatectomy, Radiation and Hormonal Therapy PSA Minimum Median Average	23 (29.5%) 8 (10.3%) 2 (2.6%) 11 (14.1%) 5 (6.4%) 8 (10.3%) 17 (21.8%) 0.02 ng/mL 1.75 ng/mL 7.90 ng/mL
Detection rate: n (%) Positive Scan Prostate/bed Lymph node Bone Soft tissue	56 (71.8%) 14 (25.0%) 45 (80.4%) 18 (32.1%) 9 (16.1%)
Lesions	N = 242
Lesion Demographics: n (%) Prostate/bed Lymph node Bone Soft tissue Histopatholigcal[asterisk] Positive Report	14 (5.8%) 195 (80.6%) 25 (10.3%) 8 (3.3%) 10 2 (20.0%)
ROC of PSA
Optimal Cut-off Sensitivity Specificity Area Under the Curve (AUC)	1.41 ng/mL 70.4% 93.8% 0.82
Management	N = 56
Change in management plan with Positive scan: n (%) Radiation Androgen-deprivation therapy Surgery & Radiation Radiation & Androgen-deprivation therapy Chemotherapy & Androgen-deprivation therapy No Change/Watchful waiting Lost to follow-up	47 (83.9%) 5 (8.9%) 8 (14.3%) 2 (3.6%) 25 (44.6%) 1 (1.8%) 9 (16.1%) 6 (10.7%)